biotech · Bladder Cancer · Non Muscle Invasive Bladder Cancer · CGON
CG Oncology
CG Oncology trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- Dallas, USA
- Founded
- 2010
- Employees
- 187
- Programs
- 8
- Drugs
- 1
- Patents
- 5
CG Oncology clinical trials
Registry index of 9 ClinicalTrials.gov studies linked to CG Oncology programs — each row shows trial ID, program name, phase, status, and indication.
CG Oncology trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for CG Oncology.
-
CG0070 Adenovirus Vector — Phase 3
Clinical update -
Cretostimogene Grenadenorepvec — Phase 3
Clinical update -
CG0070 — Phase 2
Clinical update -
CG0070 — Phase 2
Clinical update -
Cretostimogene Grenadenorepvec — Phase 2
Clinical update -
Ivaltinostat — Phase 2
Clinical update -
oncolytic adenovirus expressing GMCSF — Phase 2
Clinical update -
CG0070 — Phase 1
Clinical update